You can narrow down the results using the filters
-
A Pilot Study Investigating Cognitive Behavioural Therapy (CBT) and Mindfulness Interventions for Women Living with Persistent Pelvic Pain.
Expand descriptionThe current pilot study study aims to examine the effectiveness of an 8-session, 2-hour group, CBT and mindfulness intervention in reducing psychological distress and improving quality of life for women living with persistent pelvic pain. Women aged 18 years or over, who experience symptoms of persistent pelvic pain, will choose to participate in small group therapy intervention or Care as Usual levels (Open Label design).
-
PROMISE: Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience
Expand descriptionThis study is investigating whether routine collection of patient-reported outcome measures electronically at regular timepoints will have an impact on cancer patients symptoms and the number of hospital admissions. Who is it for? You may be eligible for this study if you are 18 or older, you have been diagnosed with an invasive solid cancer and you are about to start or have recently started treatment at one of the study hospitals in Queensland. Study details Participants enrolled in this study will be allocated to one of two study groups by chance. Participants allocated to the first group will be asked to complete a short questionnaire about their symptoms and any treatment side effects experienced on a schedule of either weekly, fortnightly or monthly depending on site the participant attends. It is anticipated that filling in the questionnaire will take about 10 minutes. Participants allocated to the second group won't be asked to complete any questionnaires prior to their treatment or follow-up visits, however, they will be asked you to complete questionnaires at regular time points over a 2 year period from consenting to the study. A pre-planned sub-study will assess the effects of the electronic symptom and treatment questionnaires on participants’ partners and/or carers (PROMISE-Carers Substudy. It is hoped this research will determine whether additional collection of patient symptoms and any treatment side effects will result more effective cancer patient care and have a positive impact on unplanned hospital presentations/admissions.
-
Understanding how Australian adults choose and follow very low calorie diet (VLCD) programs, their food and eating behaviours, and associated effects on self-perceived physical and mental health
Expand descriptionSixty-six percent of the Australian adult population are overweight or obese. Recently, there has been growing interest in very-low-calorie diets (VLCDs) for weight loss, due to greater long-term weight loss success and being more tolerable than conventional weight loss programs. This nationwide cross-sectional survey aims to understand how Australian adults choose and follow very low calorie diet (VLCD) programs, their food and eating behaviours, and associated effects on self-perceived physical and mental health.
-
Investigating the effect of a virus-based immunotherapy as a pre-surgical treatment for prostate cancer
Expand descriptionThe purpose of this study is to learn whether injecting Pexa-Vec directly into the prostate cancer or into the blood stream is a safe and useful treatment for patients with prostate cancer, before they undergo standard surgery to remove the prostate gland. Who is it for? You may be eligible for this study if you are aged 18 years or older, have been recently diagnosed with prostate cancer and you haven't received any previous cancer treatments, including surgery, androgen deprivation therapy, chemotherapy or radiotherapy. Study details Participants in this study will have a small sample of prostate tissue (biopsy) taken before they receive any treatment. The first 10 participants will have a single dose of Pexa-Vec modified viral treatment injected directly into their prostate gland while they are in an MRI scanner, at least 4 weeks prior to prostate removal surgery. The second 10 participants will have two doses of Pexa-Vec treatment injected directly into their prostrate gland while they are in an MRI scanner, the first dose will be 6 weeks prior to surgery and the second dose at least 4 weeks prior to surgery. The last 10 participants will have two doses of Pexa-Vec treatment injected into their blood stream, the first dose will be at least 5 weeks prior to surgery and the second dose at least 4 weeks prior to surgery. All participants will undergo prostate removal surgery as scheduled by their doctor and will be asked to attend a series of follow-up appointments for up to 90 days after surgery to discuss their health and any complications they might have had. It is hoped this research may be used to improve health outcomes for future patients with prostate cancer by determining whether Pexa-Vec is safe and effective at changing the appearance of tumour and immune cells, while possibly reducing tumour cell growth prior to prostate removal surgery.
-
Effect of Yeast Beta Glucan (Saccharomyces cerevisiae) compared to a placebo on cold and flu symptoms in an Adult Population – A double blind, randomised controlled trial.
Expand descriptionEffect of Yeast Beta Glucan (Saccharomyces cerevisiae) compared to a placebo on cold and flu symptoms in an Adult Population – A double blind, randomised controlled trial. The aim of this study is to assess the effectiveness of baker’s yeast beta glucan (Angel Yeast) for reducing incidence and severity of cold and flu symptoms compared to a placebo in otherwise healthy adults aged 18-65 years old.
-
The effectiveness of online menu labelling and audit and feedback in encouraging healthier food choices: a cluster randomised trial in NSW primary school canteens
Expand description -
What is the effect of a counselling training module on speech pathologists’ self-efficacy and self-report of competence for counselling in post-stroke aphasia? A Pilot Randomised Controlled Trial.
Expand descriptionAphasia, an acquired language disorder affecting everyday communication, most commonly occurs after stroke with an incidence of approximately 30% of stroke survivors. Aphasia is associated with poor mental health with a high prevalence of anxiety and depression in both stroke survivors and their families. Speech pathology services include the provision of informational and personal adjustment counselling with regard to communication disorders. Speech pathologists frequently report providing counselling to support the psychological wellbeing in this client group but the majority report low knowledge, skills, confidence, and satisfaction in this practice (Rose et al, 2014). A systematic review of counselling training for speech pathologists working with people affected by poststroke aphasia found that prequalification counseling training is variable and limited with some speech pathology training courses not offering any. Where offered, counselling training for working in poststroke aphasia is limited to less than three hours of counselling observation, coursework, and practicum. After qualification, speech pathologists seek a wide range of counselling training and approaches from external sources ranging from short courses to doctorates in counselling and psychology in an array of approaches including in motivational interviewing, solution-focused brief training, narrative therapy, and basic counselling skills (Sekhon, Oates, Kneebone & Rose, 2019). Some stroke services provide lowlevel training (by clinical psychologists) to support the psychological needs of stroke survivors. This can include, for example, person centered, solution-focused, and problem-solving approaches. However, a majority of these studies are of low quality with a variety of outcomes and unvalidated measures (checklists) used in evaluating counseling training. Counselling training (of one day or more) is significantly and positively associated with speech pathologists' selfreported confidence and competence in counselling for managing psychological concerns in stroke survivors with aphasia and their carers (Sekhon, Oates, Kneebone & Rose, 2019). Research questions: 1) What is the effect of an online counselling training module for supporting psychological wellbeing (IV) on a) speech pathologists’ self-efficacy (DV) for counselling in post-stroke aphasia? b) speech pathologists’ self-reported confidence (DV) for 8 counselling skills (including self-reported competence for counselling) relevant in post-stroke aphasia? 2) Are effects of the training maintained at 4-weeks post-training? If this training module is effective, speech pathologists who feel they have low knowledge, skills, or confidence in supporting psychological wellbeing in post-stroke aphasia rehabilitation may gain confidence and self-efficacy from undertaking this training.
-
U:DECIDE Study: Utilising technology for Diet & Exercise Change In complex chronic conditions across Diverse Environments
Expand descriptionWe are studying ways to improve cardio-metabolic health of individuals with chronic disease so that patients can better manage or avoid developing common conditions like obesity, diabetes and heart problems. The aim of this study is to determine whether using health technologies in specialist chronic disease clinics (telephone and web-based appointments and educational videos) is useful to support patients in developing healthy eating habits and regular exercise, in a way that can improve cardio-metabolic health. The information gathered from this study will be used to improve hospital clinic dietitian services, and give you the chance to assist in developing better access to health information and services that can be made available through technology
-
Let's Grow: Evaluating the efficacy of a mobile-web app on sedentary behaviour, physical activity and sleep in 2-year-old children.
Expand descriptionThis project aims to evaluate a 1 year program to increase physical activity, decrease sedentary behaviour and optimise sleep in 2 year olds. The program will be delivered via a mobile web-based application with text-message prompts.
-
Investigating the safety, satisfaction and efficacy of pulmonary tele rehabilitation for people with respiratory conditions, including patients recovering from COVID-19.
Expand descriptionThis study is investigating the safety and feasibility of providing specific pulmonary rehabilitation consisting of exercise training and education sessions to patients with respiratory conditions (including lung cancer) in their home via videoconference (telehealth). Who is it for? You may be eligible for this study if you are aged 18 or older, have an underlying respiratory condition (Chronic obstructive pulmonary disease, Bronchiectasis, interstitial lung disease, Asthma, Lung Cancer), or have recently had lung surgery, or people recovering from COVID-19 and those using long term oxygen therapy (LTOT) and have recently been treated at the Royal Prince Alfred Hospital (RPA). You also need to have access to WIFI and a home device (tablet, computer or mobile phone). Study details All participants who have been discharged from the RPA will be offered the opportunity to complete a remote (telehealth) pulmonary rehabilitation program consisting of exercise training and education specifically for people with respiratory conditions. Participants who enrol in the exercise program will be asked to complete a 40 minute exercise sessions via videoconference with a physiotherapist, twice per week for 8 weeks. Participants will also be offered a 30 minute education session once per week during the rehab program. Participants will be asked to complete two short exercise tests before and after the 8 weeks of tele rehabiltiation program, as well as some questionnaires asking about your quality of life and respiratory symptoms. Results: Seventy-five people (66 females) commenced PTR [mean (SD): Age 67 (11) years, FEV1 63 (20) % pred] and 52 (70%) completed. There was a statistically significant improvement (mean change (SD) [95% CI]) for 5STS: -4 (7) [-6 to -1] seconds; 1MinSTS: 5 (8) [2 to 9] times; SGRQ total: -7 (12) [-11 to -3] points; mMRC: -0.3 (0.7) [-0.6 to -0.7] score; CAT: -2.4 (6) [-4 to -0.5] score. No adverse events were reported.